Changeflow GovPing Pharma & Drug Safety ChangeBridge: EPO Bulletin - Biotech (C12N)
Favicon for changeflow.com

ChangeBridge: EPO Bulletin - Biotech (C12N)

RSS

Monday, March 23, 2026

Favicon for changeflow.com

Lipidoid Compounds and Related Uses Patent Publication

The European Patent Office has published patent application EP2026030466A1 concerning lipidoid compounds and their uses. The publication date is March 18, 2026. The designation of the inventor has not yet been filed.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Amyloid Accumulation Model Animal Patent Published

The European Patent Office (EPO) has published patent application EP2026029135A1 concerning an amyloid accumulation model animal. The publication date is March 18, 2026. The inventors have not yet filed their designation.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Publication EP2026028770A1 - Cytochrome P450 Protein

The European Patent Office has published patent application EP2026028770A1 concerning a cytochrome P450 protein or active fragment thereof. The publication date is March 18, 2026, and the inventors have not yet been designated.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Apparatus for Inspecting Incubating Egg Patent Publication

The European Patent Office has published a patent application (EP2026028800A1) for an apparatus designed for inspecting incubating eggs. The publication date is March 18, 2026. The inventors have not yet filed their designation.

Routine Notice Healthcare
Favicon for changeflow.com

EPO Patent Publication: Recombinant Chymotrypsin Compositions

The European Patent Office has published patent application EP2026030472A1 concerning recombinant chymotrypsin compositions and methods. The publication date is March 18, 2026, and the inventors have not yet filed their designation.

Routine Notice Pharmaceuticals

Get ChangeBridge: EPO Bulletin - Biotech (C12N) alerts

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.